Elif Bilgin
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 15
- Cancer Cells and Metastasis 5
- Peptidase Inhibition and Analysis 3
-
- Metabolism, Diabetes, and Cancer 2
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Derya Duranyıldız (20 shared papers)Faruk Taş (17 shared papers)Kayhan Ertürk (13 shared papers)Didem Taştekin (10 shared papers)Senem Karabulut (14 shared papers)Vildan Yasasever (7 shared papers)Faruk Taş (4 shared papers)Leyla Kılıç (5 shared papers)
In The Last Decade
Elif Bilgin
33 papers receiving 320 citations
Peers
Comparison fields: 5 of 60
- Internal Medicine 14
- Cancer Research 61
- Oncology 95
- Immunology and Allergy 18
- Immunology 41
Countries citing papers authored by Elif Bilgin
This map shows the geographic impact of Elif Bilgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Bilgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Bilgin more than expected).
Fields of papers citing papers by Elif Bilgin
This network shows the impact of papers produced by Elif Bilgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Bilgin. The network helps show where Elif Bilgin may publish in the future.
Co-authors
The 25 scholars most cited alongside Elif Bilgin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 26 | |
| 2 | 2016 | 23 | |
| 3 | 2014 | 20 | |
| 4 | 2017 | 20 | |
| 5 | 2014 | 18 | |
| 6 | 2012 | 17 | |
| 7 | 2015 | 16 | |
| 8 | 2014 | 13 | |
| 9 | 2014 | 12 | |
| 10 | 2017 | 12 | |
| 11 | 2013 | 12 | |
| 12 | 2015 | 11 | |
| 13 | 2015 | 11 | |
| 14 | 2013 | 9 | |
| 15 | 2016 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2016 | 8 | |
| 18 | 2012 | 8 | |
| 19 | 2019 | 7 | |
| 20 | Clinical significance of serum interleukin-17 levels in colorectal cancer patients. | 2017 | 7 |
About Elif Bilgin
Elif Bilgin is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Allergy and Cell Biology, having authored 33 papers that have together received 321 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Cancer Cells and Metastasis (5 papers), Protease and Inhibitor Mechanisms (4 papers), Cellular Mechanics and Interactions (3 papers), Peptidase Inhibition and Analysis (3 papers), Galectins and Cancer Biology (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Internal Medicine (14 citations), Cancer Research (61 citations), Oncology (95 citations), Immunology and Allergy (18 citations) and Immunology (41 citations). Elif Bilgin has collaborated with scholars based in Türkiye and Germany. Frequent co-authors include Derya Duranyıldız, Faruk Taş, Kayhan Ertürk, Didem Taştekin, Senem Karabulut, Vildan Yasasever, Faruk Taş, Leyla Kılıç, Rümeysa Çiftçi and Murat Serilmez. Their work appears in journals such as Tumor Biology, Melanoma Research, Biomedical Reports, Cytokine and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.